동물 모델 시장 : 산업 규모, 점유율, 동향, 기회, 예측 - 동물 유형별, 용도별, 유통 채널별, 지역별 및 경쟁(2021-2031년)

The Global Animal Model Market is projected to grow substantially from USD 1.97 billion in 2025 to USD 3.22 billion by 2031, exhibiting an 8.53% compound annual growth rate. These non-human organisms, including rodents, primates, and zebrafish, are crucial for scientific research, replicating human biological systems and disease pathologies to develop medical interventions. Market expansion is primarily driven by the escalating prevalence of chronic and infectious diseases necessitating extensive preclinical testing, coupled with stringent regulatory mandates requiring comprehensive safety and toxicity assessments prior to human clinical trials. Further bolstering this growth is the increasing research and development (R&D) expenditure by pharmaceutical and biotechnology companies, with global drugmakers investing nearly $288 billion in R&D in 2024, as reported by BioSpace in May 2025. This significant investment ensures a steady demand for in vivo systems, a fact underscored by Charles River Laboratories' 2024 revenue of $4.05 billion. Government funding also plays a vital role, exemplified by the National Institutes of Health (NIH) receiving $46.995 billion for FY2025, which provides essential support for academic and public research.

However, the market faces a significant challenge due to escalating ethical scrutiny and stringent international regulations on animal welfare, which increasingly promote the '3Rs' principles-Replacement, Reduction, and Refinement. These pressures lead to higher compliance costs and longer approval times for in vivo studies, redirecting research budgets towards non-animal testing methods and resulting in reduced animal usage, such as the UK's drop to approximately 77% of 2019 levels by 2025 according to the UK Bioscience Sector Coalition. Concurrently, the sector is being reshaped by key trends. The accelerated adoption of humanized immune system models is enhancing translatability, especially in immuno-oncology, with Biocytogen executing around 200 therapeutic antibody co-development and licensing agreements for its RenMice platforms by late 2024. Additionally, there's a strategic shift towards outsourcing model generation to Contract Research Organizations (CROs), driven by the complexity and cost of maintaining genetic lines in-house. This outsourcing trend is evident in Charles River Laboratories' Research Models and Services segment generating $829.4 million in annual revenue in 2024, reflecting sustained industry reliance on specialized external providers.

Market Driver

The market's growth is predominantly fueled by the increasing research and development (R&D) investments from pharmaceutical and biotechnology companies, which demand robust preclinical validation using in vivo systems for novel therapeutics. This financial commitment ensures a consistent supply chain for various animal species used in toxicology and efficacy studies. For instance, drugmakers globally invested nearly $288 billion in R&D in 2024, as noted by BioSpace in May 2025, underscoring the reliance on animal models. The sector also benefits from a surge in government funding for biomedical research, providing essential liquidity for academic and public institutions that extensively utilize genetically modified and disease-specific models. The National Institutes of Health (NIH), for example, received $46.995 billion for fiscal year 2025, according to Congress.gov in December 2025, which acts as a stabilizing force, ensuring continuous demand for biological tools in grant-funded studies.

Market Challenge

A significant impediment to the Global Animal Model Market's expansion stems from stringent international regulations concerning animal welfare and intensifying ethical scrutiny. These regulatory frameworks increasingly enforce the '3Rs' principles-Replacement, Reduction, and Refinement-mandating a systematic decrease in live animal use for scientific experimentation. This environment compels pharmaceutical and biotechnology entities to face higher compliance costs and prolonged approval timelines for in vivo studies, consequently discouraging the procurement of animal models. This redirection of research budgets toward compliance and alternative testing methods has led to reduced transaction volumes, with scientific procedures involving animals in the UK dropping to approximately 77% of 2019 levels by 2025, as reported by the UK Bioscience Sector Coalition, thereby dampening revenue potential.

Market Trends

The market is undergoing transformative shifts, notably with the accelerated adoption of humanized immune system models. These advanced biological systems are becoming vital for improving the translatability of preclinical studies to human clinical outcomes, particularly in immuno-oncology, by replacing murine immune components with functional human counterparts. This trend is quantitatively demonstrated by Biocytogen's execution of approximately 200 therapeutic antibody co-development and licensing agreements for its RenMice humanized model platforms by the end of 2024, as per their June 2025 press release. Additionally, a strategic shift towards outsourcing model generation to Contract Research Organizations (CROs) is evident. This move, driven by the increasing complexity and cost of maintaining sophisticated genetic lines in-house, allows pharmaceutical developers to convert fixed infrastructure costs into variable service expenditures while leveraging specialized technical expertise. Charles River Laboratories' Research Models and Services (RMS) segment, which generated $829.4 million in annual revenue in 2024, as reported in February 2025, exemplifies the industry's sustained reliance on outsourced model management and production capabilities.

Key Market Players

• Charles River Laboratories International Inc.
• The Jackson Laboratory
• Taconic Biosciences, Inc.
• Janvier Labs S.A.S.
• HBM Holdings Limited
• Crown Bioscience Inc.
• Inotiv Inc.
• Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
• BioSpherix, Ltd

Report Scope

In this report, the Global Animal Model Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Animal Model Market, By Animal Type

• Mice
• Rat
• Guinea Pigs
• Rabbits
• Hamsters
• Others

Animal Model Market, By Application

• Cancer
• Immunological Disease
• Infectious Disease
• Others

Animal Model Market, By Distribution Channel

• Pharmaceutical & Biotechnology Companies
• Academic Research Institute
• Contract Research Organization

Animal Model Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Animal Model Market.

Available Customizations:

Global Animal Model Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Animal Model Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Animal Type (Mice, Rat, Guinea Pigs, Rabbits, Hamsters, Others)
  • 5.2.2. By Application (Cancer, Immunological Disease, Infectious Disease, Others)
  • 5.2.3. By Distribution Channel (Pharmaceutical & Biotechnology Companies, Academic Research Institute, Contract Research Organization)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Animal Model Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Animal Type
  • 6.2.2. By Application
  • 6.2.3. By Distribution Channel
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Animal Model Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Animal Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By Distribution Channel
  • 6.3.2. Canada Animal Model Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Animal Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By Distribution Channel
  • 6.3.3. Mexico Animal Model Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Animal Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By Distribution Channel

7. Europe Animal Model Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Animal Type
  • 7.2.2. By Application
  • 7.2.3. By Distribution Channel
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Animal Model Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Animal Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By Distribution Channel
  • 7.3.2. France Animal Model Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Animal Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By Distribution Channel
  • 7.3.3. United Kingdom Animal Model Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Animal Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By Distribution Channel
  • 7.3.4. Italy Animal Model Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Animal Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By Distribution Channel
  • 7.3.5. Spain Animal Model Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Animal Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By Distribution Channel

8. Asia Pacific Animal Model Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Animal Type
  • 8.2.2. By Application
  • 8.2.3. By Distribution Channel
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Animal Model Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Animal Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By Distribution Channel
  • 8.3.2. India Animal Model Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Animal Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By Distribution Channel
  • 8.3.3. Japan Animal Model Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Animal Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By Distribution Channel
  • 8.3.4. South Korea Animal Model Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Animal Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By Distribution Channel
  • 8.3.5. Australia Animal Model Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Animal Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By Distribution Channel

9. Middle East & Africa Animal Model Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Animal Type
  • 9.2.2. By Application
  • 9.2.3. By Distribution Channel
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Animal Model Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Animal Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By Distribution Channel
  • 9.3.2. UAE Animal Model Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Animal Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By Distribution Channel
  • 9.3.3. South Africa Animal Model Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Animal Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By Distribution Channel

10. South America Animal Model Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Animal Type
  • 10.2.2. By Application
  • 10.2.3. By Distribution Channel
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Animal Model Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Animal Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By Distribution Channel
  • 10.3.2. Colombia Animal Model Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Animal Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By Distribution Channel
  • 10.3.3. Argentina Animal Model Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Animal Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Animal Model Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Charles River Laboratories International Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. The Jackson Laboratory
• 15.3. Taconic Biosciences, Inc.
• 15.4. Janvier Labs S.A.S.
• 15.5. HBM Holdings Limited
• 15.6. Crown Bioscience Inc.
• 15.7. Inotiv Inc.
• 15.8. Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
• 15.9. BioSpherix, Ltd

16. Strategic Recommendations

17. About Us & Disclaimer